Tuesday - July 15, 2025

Gene Therapy Market to Hit US$36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™

Biogen had the largest share in gene therapy market. Biogen is a biotechnology company specializing in developing therapies for diseases like multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease. Biogen Inc. (US), Novartis AG (Switzerland), and Alnylam Pharmaceuticals, Inc. (US) are holding … Continue reading